Fetal gene therapy for neurodegenerative disease of infants

Fetal gene therapy for neurodegenerative disease of infants

For inherited genetic diseases, fetal gene therapy offers the potential of prophylaxis against early, irreversible and lethal pathological change. To explore this, we studied neuronopathic Gaucher disease (nGD), caused by mutations in GBA. In adult patients, the milder form presents with hepatomegal...

Full description

Bibliographic Details
Main Authors:	Massaro, G, Mattar, C, Wong, A, Huebecker, M, Priestman, D, Platt, F, al., E
Format:	Journal article
Published:	Springer Nature 2018

Similar Items

Lysosomal dysfunction and glycosphingolipid dysregulation in rare and common neurodegenerative diseases
by: Huebecker, M
Published: (2019)

Systemic AAV9 gene therapy using the synapsin I promoter rescues a mouse model of neuronopathic Gaucher disease but with limited cross-correction potential to astrocytes
by: Massaro, G, et al.
Published: (2020)

Imino sugar therapy for type 1 Gaucher disease.
by: Priestman, D, et al.
Published: (2000)

Haematopoietic stem cell transplantation arrests the progression of neurodegenerative disease in late-onset Tay-Sachs disease
by: Stepien, K, et al.
Published: (2017)

Anti-TNF therapy for inflammatory bowel disease in patients with neurodegenerative Niemann-Pick disease Type C
by: Williams, I, et al.
Published: (2022)

Reduced sphingolipid hydrolase activities, substrate accumulation and ganglioside decline in Parkinson’s disease
by: Huebecker, M, et al.
Published: (2019)

AAV9 intracerebroventricular gene therapy improves lifespan, locomotor function and pathology in a mouse model of Niemann-Pick type C1 disease
by: Hughes, MP, et al.
Published: (2018)

Gene Therapy for Neurodegenerative Disease: Clinical Potential and Directions
by: Xiaolin Zhu, et al.
Published: (2021-06-01)

Glycosphingolipid levels and glucocerebrosidase activity are altered in normal aging of mouse brain
by: Hallett, PJ, et al.
Published: (2018)

Lucerastat, an iminosugar for substrate reduction therapy in Fabry Disease: Preclinical evidence
by: Welford, R, et al.
Published: (2017)

Gene therapy of neurodegenerative diseases: achievements, developments, and clinical implementation challenges
by: E. V. Melnikova, et al.
Published: (2023-06-01)

Nutritional and biochemical therapies for neurodegenerative diseases
by: George E. Barreto
Published: (2015-04-01)

Reduced sphingolipid hydrolase activities, substrate accumulation and ganglioside decline in Parkinson’s disease
by: Mylene Huebecker, et al.
Published: (2019-11-01)

Correction to: Reduced sphingolipid hydrolase activities, substrate accumulation and ganglioside decline in Parkinson’s disease
by: Mylene Huebecker, et al.
Published: (2020-01-01)

Sirtuins in the pathogenetic therapy of neurodegenerative diseases
by: Ekaterina M. Samoilova, et al.
Published: (2024-04-01)

Prodrug Therapies for Infectious and Neurodegenerative Diseases
by: Milica Markovic, et al.
Published: (2022-02-01)

Progress and prospects: Immunobiology of gene therapy for neurodegenerative disease: prospects and risks.
by: McMenamin, M, et al.
Published: (2010)

Management of Neuroinflammatory Responses to AAV-Mediated Gene Therapies for Neurodegenerative Diseases
by: Barbara A. Perez, et al.
Published: (2020-02-01)

Current advances in combining stem cell and gene therapy for neurodegenerative diseases
by: Ji-Yoon Hwang, et al.
Published: (2018-06-01)

Inhibition of β-glucocerebrosidase activity preserves motor unit integrity in a mouse model of amyotrophic lateral sclerosis
by: Henriques, A, et al.
Published: (2017)

N-Butyl-L-Deoxynojirimycin (L-NBDNJ): Synthesis of an allosteric enhancer of α-glucosidase activity for the treatment of Pompe disease
by: D'Alonzo, D, et al.
Published: (2017)

Altered expression of ganglioside metabolizing enzymes results in GM3 ganglioside accumulation in cerebellar cells of a mouse model of juvenile neuronal ceroid lipofuscinosis
by: Somogyi, A, et al.
Published: (2018)

RNA therapy for polyglutamine neurodegenerative diseases.
by: Watson, L, et al.
Published: (2012)

RNA therapy for polyglutamine neurodegenerative diseases.
by: Watson, L, et al.
Published: (2012)

Gene therapy for childhood neuromuscular and neurodegenerative disorders: An update
by: Prateek Kumar Panda
Published: (2019-01-01)

Gene therapy for neurodegenerative disorders: advances, insights and prospects
by: Wei Chen, et al.
Published: (2020-08-01)

Extracellular vesicles, from the pathogenesis to the therapy of neurodegenerative diseases
by: Xiaohuan Xia, et al.
Published: (2022-12-01)

Labeling of Disease-Modifying Therapies for Neurodegenerative Disorders
by: Anne Vinther Morant, et al.
Published: (2019-10-01)

Lucerastat, an iminosugar for substrate reduction therapy in Fabry disease: preclinical evidence
by: Priestman, D, et al.
Published: (2017)

Analysis of neurodegenerative disease-causing genes in dementia with Lewy bodies
by: Orme, T, et al.
Published: (2020)

Designing and optimizing AAV-mediated gene therapy for neurodegenerative diseases: from bench to bedside
by: Liang Xu, et al.
Published: (2024-09-01)

Characteristics and advantages of adeno-associated virus vector-mediated gene therapy for neurodegenerative diseases
by: Yuan Qu, et al.
Published: (2019-01-01)

Genetic background modifies phenotypic severity and longevity in a mouse model of Niemann-Pick disease type C1
by: Rodriguez-Gil, J, et al.
Published: (2020)

Increased glycosphingolipid levels in serum and aortae of apolipoprotein E gene knockout mice.
by: Garner, B, et al.
Published: (2002)

CRISPR/Cas9: implications for modeling and therapy of neurodegenerative diseases
by: Weili eYang, et al.
Published: (2016-04-01)

Analysis of neurodegenerative disease-causing genes in dementia with Lewy bodies
by: Tatiana Orme, et al.
Published: (2020-01-01)

The apo E gene knockout mouse as a model to study the potential atherogenic properties of glycosphingolipids
by: Garner, B, et al.
Published: (2003)

Antenatal steroids elicited neurodegenerative-associated transcriptional changes in the hippocampus of preterm fetal sheep independent of lung maturation
by: Sean W. D. Carter, et al.
Published: (2024-08-01)

Growth Factors and Their Application in the Therapy of Hereditary Neurodegenerative Diseases
by: Shaza Issa, et al.
Published: (2024-08-01)

Impact of TRPV1 on Pathogenesis and Therapy of Neurodegenerative Diseases
by: Wenxin Wang, et al.
Published: (2023-12-01)